Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: WHL who wrote (82)	2/11/1999 6:38:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 946

That is not true...in the previous post we have a reference to an article in the WSL (sic)...WSJ, which is also mentioned on the Yahoo board. Probably the stock is reacting to that article. Here is a rather cynical post on the yahoo thread...but worth reading messages.yahoo.com@m2.yahoo.com if the link fails, it is post 1116 CTIC, like a lot of biotechs certainly does seem undervalued at $4...I don't happen to own it at the moment, but that's only because I wanted to go nuts on some other ideas. I read through everything that Cell T sent me and have nothing bad to say. Do you know if there is a chance that any analysts are going to start covering ctic...the yahoo reasearch url suggests that nobody is covering them right now. (That shouldn't matter, but if coverage is inititated and a round of buying kicks in, that would be nice...)